The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells

Journal of Leukocyte Biology

Volumn 63, Issue 4, 1998, Pages 418-428

  Mackey, Matthew F ^a   Barth Jr , Richard J ^a   Noelle, Randolph J ^a,b  

^a NORRIS COTTON CANCER CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cell mediated immunity; Cross priming; T cell; Tumor

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL MATURATION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031977605     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.4.418     Document Type: Review

References (105)

1. Stamenkovic, I., Clark, E. A., Seed, B. (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410.
2. Baker, S. J., Reddy, E. P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins [Review]. Oncogene 12, 1-9.
3. Inaba, L., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Maramatsu, S., Hodes, R. J., Steinman, R. M. (1994) The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860.
4. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., Spriggs, M. K. (1993) CD40 expression by monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178, 669-674.
5. Fanslow, W. C., Clifford, K. N., Seaman, M., Alderson, M. R., Spriggs, M. K., Armitage, R. J., Ramsdell, F. (1994) Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152, 4262-4269.
6. Armitage, R. J., Tough, T. W., Macduff, B. M., Fanslow, W. C., Spriggs, M. K., Ramsdell, F., Alderson, M. R. (1993) CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23, 2326-2331.
7. Ruggiero, G., Caceres, E. M., Voordouw, A., Noteboom, E., Graf, D., Kroczek, R. A., Spits, H. (1996) CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes. J. Immunol. 156, 3737-3746.
8. Karmann, K., Hughes, C. W., Schechner, J., Fanslow, W. C., Pober, J. S. (1995) CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92, 4342-4346.
9. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfield, R. W., Kiener, P. A., Aruffo, A. (1995) Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33-40.
10. Peguet-Navarro, J., Dalbiez-Gauthier, C., Moulon, C., Berthier, O., Reano, A., Gaucherand, M., Banchereau, J., Rousset, F., Schmitt, D. (1997) CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J. Immunol. 158, 144-152.
11. Denfeld, R. W., Hollenbaugh, D., Fehrenbach, A., Weiss, J. M., Von Leoprechting, A., Mai, B., Voith, U., Schopf, E., Aruffo, A., Simon, J. C. (1996) CD40 is functionally expressed on human keratinocytes. Eur. J. Immunol. 26, 2329-2334.
12. Yellin, M. J., Winikoff, S., Fortune, S. M., Baum, D., Crow, M. K., Lederman, S., Chess, L. (1995) Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and 1L-6 production and proliferation. J. Leukoc. Biol. 58, 209-216.
13. Clark, E. A., Lane, P. J. L. (1991) Regulation of human B cell activaiton and adhesion. Annu. Rev. Immunol. 9, 97-127.
14. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van, K. C., Durand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
15. Peguet, N. J., Dalbiez, G. C., Rattis, F. M., Van, K. C., Banchereau, J., Schmitt, D. (1995) Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 155, 4241-4247.
16. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., Clark, E. A., Smith, C. A., Grabstein, K. H., Cosman, D., Spriggs, M. K. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82.
17. Hollenbaugh, D., Grosmaire, L., Kullas, C. D., Chalupny, N. J., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., Aruffo, A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11, 4313-4321.
18. + T cells. J. Immunol. 151, 2497-2510.
19. + type 2 cytotoxic T cells restricts their potential B cell helper activity. Eur. J. Immunol. 27, 914-922.
20. + T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25, 2972-2977.
21. Gauchat, J.F., Henchoz, S., Fattah, D., Mazzei, G., Aubry, J. P., Jomotte, T., Dash, L., Page, K., Solari, R., Aldebert, D. et al. (1995) CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25, 863-865.
22. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores, R. L., Thompson, J. (1993) Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343.
23. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Karre, K., Zappacosta, S. (1997) A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
24. Pinchuk, L. M., Klaus, S. J., Magaletti, D. M., Pinchuk, G. V., Norsen, J. P., Clark, E. A. (1996) Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J. Immunol. 157, 4363-4370.
25. Jaiswal, A. I., Croft, M. (1997) CD40 ligand induction on T cell subsets by peptide-presenting B cells. J. Immunol. 159, 2282-2291.
26. Dubey, C., Croft, M., Swain, S. L. (1996) Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157, 3280-3289.
27. Roy, M., Aruffo, A., Ledbetter, J. A., Linsley, P., Kehry, M., Noelle, R. J. (1995) Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25, 596-603.
28. Ding, L., Green, J. M., Thompson, C. B., Shevach, E. M. (1995) B7/CD28-dependent and -independent induction of CD40 ligand expression. J. Immunol. 155, 5124-5132.
29. Grewal, I. S., Xu, J., Flavell, R. A. (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378, 617-620.
30. Van Essen, D., Kikutani, H., Gray, D. (1995) CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
31. Grewal, I. S., Foellmer, H. G., Grewal, K. D., Xu, J., Hardardottir, F., Baron, J. L., Janeway, C. A., Jr., Flavell, R. A. (1996) Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273, 1864-1867.
32. Yang, Y., Wilson, J. M. (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273, 1862-1864.
33. Scaria, A., St, G. J., Gregory, R. J., Noelle, R. J., Wadsworth, S. C., Smith, A. E., Kaplan, J. M. (1997) Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther. 4, 611-617.
34. Durie, F. H., Aruffo, A., Ledbetter, J. A., Crassi, K. M., Green, W. R., Noelle, R. J. (1994) Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-versus-host disease. J. Clin. Invest. 94, 1333-1338.
35. Jenkins, M. K., Pardoll, J., Mizuguchi, J., Chused, T. M., Schwartz, R. H. (1987) Molecular events for the induction of a nonresponsiveness state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl. Acad. Sci. USA 84, 5409-5413.
36. Mondino, A., Khoruts, A., Jenkins, M. K. (1996) The anatomy of T-cell activation and tolerance [Review]. Proc. Natl. Acad. Sci. USA 93, 2245-2252.
37. Lenschow, D. J., Walunas, T. L., Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation [Review]. Annu. Rev. Immunol. 14, 233-258.
38. Kiener, P. A., Moran, D. P., Rankin, B. M., Wahl, A. F., Aruffo, A., Hollenbaugh, D. (1995) Stimulation of CD40 with purified soluble gp39 induces proinflamrnatory responses in human monocytes. J. Immunol. 155, 4917-4925.
39. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., Alber, G. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752.
40. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Ottene-Evans, C. A., Janeway, C. A., Grabstein, K. H. (1994) Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24, 116-123.
41. Ranheim, E. A., Kipps, T. J. (1993) Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177, 925-935.
42. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., Noelle, R. J. (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15, 406-411.
43. Hollander, G. A., Castigli, E., Kulbacki, R., Su, M., Burakoff, S. J., Gutierrez-Ramos, J. C., Geha, R. S. (1996) Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc. Natl. Acad. Sci. USA 93, 4994-4998.
44. Buhlmann, J. E., Foy, T. M., Aruffo, A., Crassi, K. M., Ledbetter, J. A., Green, W. R., Xu, J. C., Shultz, L. D., Roopesian, D., Flavell, R. A., Fast, L., Noelle, R. J., Durie, F. H. (1995) In the absence of a CD40 Signal, B cells are tolerogenic. Immun. 2, 645-653.
45. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker, B. C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., Pearson, T. C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
46. Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P., Rossini, A. A. (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92, 9560-9564.
47. Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, V., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H. J., Knechtle, S. J. (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94, 8789-8794.
48. Matzinger, P. (1994) Tolerance, danger, and the extended family [Review]. Annu. Rev. Immunol. 12, 991-1045.
49. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
50. Cella, M., Engering, A., Pinet, V., Pieters, J., Lanzavecchia, A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787.
51. Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C., Morris, S. C. (1996) Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157, 1406-1414.
52. Vella, A. T., Scherer, M. T., Schultz, L., Kappler, J. W., Marrack, P. (1996) B cells are not essential for peripheral T-cell tolerance. Proc. Natl. Acad. Sci. USA 93, 951-955.
53. Vella, A. T., McCormack, J. E., Linsley, P. S., Kappler, J. W., Marrack, P. (1995) Lipopolysaccharide interferes with the induction of peripheral T cell death. Immun. 2, 261-270.
54. Vella, A. T., Mitchell, T., Groth, B., Linsley, P. S., Green, J. M., Thompson, C. B., Kappler, J. W., Marrack, P. (1997) CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158, 4714-4720.
55. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J., Kim, J., Goldberg, J. M., Hathcock, K., Laszlo, G., Lombard, L. A., Wang, S., Gray, G. S., Nadler, L. M., Sharpe, A. H. (1993) Murine B7-2, an alternative CTLA-4 counter-receptor that co-stimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178, 2185-2192.
56. + T cell functions. J. Exp. Med. 183, 2209-2218.
57. Whitmire, J. K., Slifka, M. K., Grewal, I. S., Flavell, R. A., Ahmed, R. (1996) CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection [published erratum appears in J. Virol. 71, 1736]. J. Virol. 70, 8375-8381.
58. + CTL response. J. Exp. Med. 183, 2129-2142.
59. Griggs, N. D., Agersborg, S. S., Noelle, R. J., Ledbetter, J. A., Linsley, P. S., Tung, K. S. (1996) The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183, 801-810.
60. Janeway, C. A., Jr. (1992) The immune system evolved to discriminate infectious nonself from noninfectious serf [Review]. Immunol. Today 13, 11-16.
61. Bluestone, J. A. (1995) New perspectives of CD28-B7 mediated T cell costimulation. Cell 2, 555-559.
62. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A., Thompson, C. B. (1994) Absence of B7-dependent responses in CD28-deficient mice. Immunity 1, 501-508.
63. Kundig, T. M., Shahinian, A., Kawai, K., Mittrucker, H. W., Sebzda, E., Bachmann, M. F., Mak, T. W., Ohashi, P. S. (1996) Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5, 41-52.
64. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158, 29-39.
65. + T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 182, 1579-1584.
66. + T cells. J. Immunol. 154, 5071-5079.
67. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity [Review]. Annu. Rev. Immunol. 13, 251-276.
68. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., Glimcher, L. H. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
69. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S., Gribben, J. G., Nadler, L. M. (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
70. Pretolani, M., Goldman, M. (1997) IL-10: a potential therapy for allergic inflammation?. [Review]. Immunol. Today 18, 277-280.
71. Koch, F., Stanzyl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N., Schuler, G. (1996) High level IL12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL4 and IL10. J. Exp. Med. 184, 741-746.
72. Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G., Maliszewski, C. R. (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289.
73. Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., Delepesse, G. (1995) Activated T cells induce interleukin 12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25, 1125-1128.
74. Kelsall, B. L., Stuber, E., Neurath, M., Strober, W. (1996) Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann. NY Acad. Sci. 795, 116-126.
75. Stuber, E., Strober, W., Neurath, M. (1996) Blocking of CD40-CD40L interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183, 693-698.
76. Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., Kikutani, H. (1996) Protective role of CD40 in Leishmania major infection at two distincts phases of cell-mediated immunity. Immunity 4, 275-281.
77. Soong, L., Xu, J. C., Grewal, I. S., Kima, P., Sun, J., Longely, B. J., Ruddle, N. H., McMahon-Pratt, D., Flavell, R. A. (1996) Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273.
78. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., Mulligan, R. C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
79. Shu, S. Y., Rosenberg, S. A. (1985) Adoptive immunotherapy of newly induced murine sarcomas. Cancer Res. 45, 1657-1662.
80. Chou, T., Shu, S. (1987) Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. J. Immunol. 139, 2103-2109.
81. Yang, Y., Xiang, Z., Ertl, H. C., Wilson, J. M. (1995) Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.
82. Liu, B., Podack, E. R., Allison, J. P., Malek, T. R. (1996) Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J. Immunol. 156, 1117-1125.
83. Kawakami, Y., Rosenberg, S. A., Lotze, M. T. (1988) Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med. 168, 2183-2191.
84. Jondal, M., Schirmbeck, R., Reimann, J. (1996) MHC class I-restricted CTL responses to exogenous antigens [Review]. Immunity. 5, 295-302.
85. Shen, Z., Reznikoff, G., Dranoff, G., Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730.
86. Kovacsovics-Bankowski, M., Rock, K. L. (1995) A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246.
87. Rock, K. L., Rothstein, L., Gamble, S., Fleischacker, C. (1993) Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150, 438-446.
88. Kovacsovics-Bankowski, M., Rock, K. L. (1994) Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur. J. Immunol. 24, 2421-2428.
89. Doe, B., Selby, M., Barnett, S., Baenziger, J., Walker, C. M. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578-8583.
90. Huang, A. Y. C., Golumbek, P., Ahmadzedeh, M., Jaffee, E., Pardoll, D., Levitsky, H. (1994) Role of bone marrow-derived cells in presenting MHC Class I-restricted tumor antigens. Science 264, 961-965.
91. Huang, A. Y., Bruce, A. T., Pardoll, D. M., Levitsky, H. I. (1996) In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4, 349-355.
92. Huang, A. Y., Bruce, A. T., Pardoll, D. M., Levitsky, H. I. (1996) Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183, 769-776.
93. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., Storkus, W. J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines [see comments]. J. Exp. Med. 183, 87-97.
94. Levitsky, H. I., Lazenby, A., Hayashi, R. J., Pardoll, D. M. (1994) In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J. Exp. Med. 179, 1215-1224.
95. Porgador, A., Gilboa, E. (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255-260.
96. Porgador, A., Snyder, D., Gilboa, E. (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156, 2918-2926.
97. Mackey, M. F., Gunn, J. R., Ting, P. P., Kikutani, H., Dranoff, G., Noelle, R. J., Barth, R. J. (1997) Protective immunity induced by tumor vaccines requires interaction between CD40 and it ligand, CD154. Cancer Res. 57, 2569-2574.
98. + T cell help. J. Exp. Med. 186, 65-70.
99. Yang, Y., Ertl, H. C., Wilson, J. M. (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1, 433-442.
100. Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., Claassen, E. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499-2504.
101. Malik, N., Greenfield, B. W., Wahl, A. F., Kiener, P. A. (1996) Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156, 3952-3960.
102. + T cells in response to MIP-1 alpha and MIP-1 beta. Science 260, 355-358.
103. Wiley, J. A., Geha, R., Harmsen, A. G. (1997) Exogenous CD40 ligand induces a pulmonary inflammation response. J. Immunol. 158, 2932-2938.
104. Stout, R. D., Suttles, J., Xu, J., Grewal, I. S., Flavell, R. A. (1996) Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156, 8-11.
105. Liew, F. Y., Millott, S., Parkinson, C., Palmer, R. M., Moncada, S. (1990) Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144, 4794-4797.